(Total Views: 567)
Posted On: 04/06/2020 5:26:10 PM
Post# of 154901
Haven't read this yet but just got it:
https://www.otcmarkets.com/filing/html?id=140...emXQTYUt3h
https://www.otcmarkets.com/filing/html?id=140...emXQTYUt3h
Quote:
Item 1.01. Entry into a Material Definitive Agreement.
On March 31, 2020, CytoDyn Inc. (the “Company”) entered into a Securities Purchase Agreement (the “Agreement”) pursuant to which the Company issued a secured convertible promissory note, as amended (the “Note”) with a two-year maturity to an institutional accredited investor (the “Investor”) in the initial principal amount of $17.1 million. The Note is secured by all of the assets of the Company, excluding the Company’s intellectual property. The Investor gave consideration of $15.0 million, reflecting original issue discount of $2.1 million. The Company anticipates using the proceeds for general working capital purposes.
(0)
(0)
